References
- Beer M, Sandstede J, Landschuetz W, Viehrig M, Harre K, Horn M, et al. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol 2000;10:1323–8.
- Blamire AM, Rajagopalan B, Radda GK. Measurement of myocardial pH by saturation transfer in man. Magn Reson Med 1999;41:198–203.
- Bottomley PA. MR spectroscopy of the human heart: the status and the challenges. Radiology 1994;191: 593–612.
- Buchthal SD, den Hollander JA, Merz CN, Rogers WJ, Pepine CJ, Reichek N, et al. Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. N Engl J Med 2000;342:829–35.
- Chida K, Saito H, Nagasaka T, Otani H, Kohzuki M, Zuguchi M. Rapid-sequence phosphorus-31 magnetic resonance spectroscopy of the human heart using a 1.5 T clinical system. Acta Radiol 2004;45: 30–7.
- Conway MA, Allis J, Ouwerkerk R, Niioka T, Rajagopalan B, Radda GK, et al. Detection of low phosphocreatine to ATP ratio in hypertrophied human myocardium by 31P magnetic resonance spectroscopy. Lancet 1991;338:973–6.
- Conway A, Bottomley PA, Ouwerkerk R, Radda GK, Rajagopalan B. Mitral regurgitation impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998;97:1716–23.
- Hardy CJ, Weiss RG, Bottomley PA, Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991;122:795–801.
- Henriksen O. MR spectroscopy in clinical research. Acta Radiol 1994;35:96–116.
- Hetherington HP, Luney DJ, Vaghan JT, Pan JW, Ponder SL, Tschendel O, et al. 3D 31P spectroscopic imaging of the human heart at 4.1 T. Magn Reson Med 1995;33:427–31.
- Jung W-I, Sieverding L, Breuer J, Hoess T, Widmaier S, Schmidt O, et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. Circulation 1998;97: 2536–42.
- Kalil-Filho R, Albuquerque CP, Weiss RG. Normal high energy phosphate ratios in "Stunned" human myocardium. J Am Coll Cardiol 1997;30: 1228–32.
- Loffler R, Sauter R, Kolem H, Haase A, von Klenlin K. Localized spectroscopy from anatomically matched compartments: improved sensitivity and localization for cardiac 31P MRS in humans. J Magn Reson 1998;134: 287–99.
- Neubauer S, Horn M, Cramer M, Harre K, Newell JB, Peters W, et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy. Circulation 1997;96:2190–6.
- Neubauer S, Horn M, Pabst T, Harre K, Stromer H, Bertsch G, et al. Cardiac high-energy metabolism in patients with aortic valve disease assessed by 31P-magnetic resonance spectroscopy. J Investig Med 1997; 45:453–62.
- von Kienlin M, Beer M, Greiser A, Hahn D, Harre K, Kostler H, et al. Advances in human cardiac 31P-MR spectroscopy: SLOOP and clinical applications. J Magn Reson Imag 2001;13:521–7.
- Weiss RG, Kalil-Filho R, Bottomley PA. Clinical cardiac magnetic spectroscopy: In: Manning WJ, Pennell DJ, editors. Cardiovascular magnetic resonance. New York: Churchill Livingstone; 2002. p. 437–46.